questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines tumorales
Protéines oncogènes
Protéines proto-oncogènes
Protéines proto-oncogènes c-hck
Protéines proto-oncogènes c-hck : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes c-hck : Questions médicales les plus fréquentes",
"headline": "Protéines proto-oncogènes c-hck : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines proto-oncogènes c-hck : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-hck"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines proto-oncogènes",
"url": "https://questionsmedicales.fr/mesh/D011518",
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes",
"code": {
"@type": "MedicalCode",
"code": "D011518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.624.664.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéines proto-oncogènes c-hck",
"alternateName": "Proto-Oncogene Proteins c-hck",
"code": {
"@type": "MedicalCode",
"code": "D051572",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yan Wang",
"url": "https://questionsmedicales.fr/author/Yan%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Center of Genetic Medicine, The affiliated Obstetrics and Gynecology Hospital with Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China."
}
},
{
"@type": "Person",
"name": "Changchuan Xie",
"url": "https://questionsmedicales.fr/author/Changchuan%20Xie",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Xi Huang",
"url": "https://questionsmedicales.fr/author/Xi%20Huang",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Johanna Stachelscheid",
"url": "https://questionsmedicales.fr/author/Johanna%20Stachelscheid",
"affiliation": {
"@type": "Organization",
"name": "Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany."
}
},
{
"@type": "Person",
"name": "Qu Jiang",
"url": "https://questionsmedicales.fr/author/Qu%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical Informatics in Critical Care Medicine.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37780994",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.59249/WTTU3055"
}
},
{
"@type": "ScholarlyArticle",
"name": "Why is biomedical informatics hard? A fundamental framework.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36893995",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbi.2023.104327"
}
},
{
"@type": "ScholarlyArticle",
"name": "Implementing a Novel Interprofessional Clinical Informatics Curriculum.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/35213472",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CIN.0000000000000855"
}
},
{
"@type": "ScholarlyArticle",
"name": "Applied Clinical Informatics Journal: A Brief History.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/35584790",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1749165"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Leaders in Informatics, Quality, and Systems (LInQS) Fellowship.",
"datePublished": "2024-10-30",
"url": "https://questionsmedicales.fr/article/39477247",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0044-1790550"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines tumorales",
"item": "https://questionsmedicales.fr/mesh/D009363"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines oncogènes",
"item": "https://questionsmedicales.fr/mesh/D015513"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines proto-oncogènes",
"item": "https://questionsmedicales.fr/mesh/D011518"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines proto-oncogènes c-hck",
"item": "https://questionsmedicales.fr/mesh/D051572"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines proto-oncogènes c-hck - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines proto-oncogènes c-hck",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines proto-oncogènes c-hck",
"description": "Comment diagnostiquer une anomalie des protéines c-hck ?\nQuels tests sont utilisés pour détecter c-hck ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels marqueurs tumoraux sont associés à c-hck ?\nPeut-on utiliser l'imagerie pour diagnostiquer c-hck ?",
"url": "https://questionsmedicales.fr/mesh/D051572?mesh_terms=Medical+Informatics&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines proto-oncogènes c-hck",
"description": "Quels symptômes sont liés aux anomalies de c-hck ?\nLes anomalies de c-hck causent-elles des douleurs ?\nY a-t-il des symptômes spécifiques au cancer lié à c-hck ?\nLes symptômes apparaissent-ils rapidement ?\nLes anomalies de c-hck affectent-elles le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D051572?mesh_terms=Medical+Informatics&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines proto-oncogènes c-hck",
"description": "Peut-on prévenir les anomalies de c-hck ?\nY a-t-il des dépistages recommandés ?\nL'alimentation influence-t-elle c-hck ?\nLe tabagisme est-il un facteur de risque pour c-hck ?\nL'exercice physique aide-t-il à prévenir c-hck ?",
"url": "https://questionsmedicales.fr/mesh/D051572?mesh_terms=Medical+Informatics&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines proto-oncogènes c-hck",
"description": "Quels traitements ciblent les anomalies de c-hck ?\nLa chimiothérapie est-elle efficace contre c-hck ?\nLes traitements sont-ils personnalisés pour c-hck ?\nLa radiothérapie est-elle une option pour c-hck ?\nQuels effets secondaires peuvent survenir avec les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D051572?mesh_terms=Medical+Informatics&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines proto-oncogènes c-hck",
"description": "Quelles complications peuvent survenir avec c-hck ?\nLes anomalies de c-hck affectent-elles la survie ?\nY a-t-il des complications liées aux traitements ?\nLes complications sont-elles réversibles ?\nComment gérer les complications liées à c-hck ?",
"url": "https://questionsmedicales.fr/mesh/D051572?mesh_terms=Medical+Informatics&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines proto-oncogènes c-hck",
"description": "Quels sont les principaux facteurs de risque pour c-hck ?\nL'âge est-il un facteur de risque pour c-hck ?\nLes infections virales sont-elles un facteur de risque ?\nLe stress a-t-il un impact sur c-hck ?\nL'exposition à des produits chimiques est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D051572?mesh_terms=Medical+Informatics&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des protéines c-hck ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de tissus tumoraux peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter c-hck ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'immunohistochimie et les tests de PCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies permettent d'examiner les tissus et de détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés à c-hck ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme le CD45 et d'autres protéines peuvent être associés à c-hck."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour diagnostiquer c-hck ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à localiser les tumeurs, mais ne détecte pas c-hck directement."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies de c-hck ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, mais peuvent inclure fatigue, perte de poids et douleurs."
}
},
{
"@type": "Question",
"name": "Les anomalies de c-hck causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de la croissance tumorale associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques au cancer lié à c-hck ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes spécifiques dépendent du type de cancer, comme des saignements ou des masses."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent se développer lentement ou rapidement, selon le type de cancer."
}
},
{
"@type": "Question",
"name": "Les anomalies de c-hck affectent-elles le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent altérer la réponse immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de c-hck ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des dépistages recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépistages réguliers pour certains cancers peuvent aider à une détection précoce."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle c-hck ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de cancer, mais ne prévient pas c-hck spécifiquement."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque pour c-hck ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour plusieurs types de cancer."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir c-hck ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut réduire le risque de cancer en général, mais pas spécifiquement c-hck."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les anomalies de c-hck ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies ciblées et l'immunothérapie sont des options de traitement possibles."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace contre c-hck ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie peut être utilisée, mais son efficacité dépend du type de cancer."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés pour c-hck ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des caractéristiques génétiques."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle une option pour c-hck ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie peut être utilisée pour traiter les tumeurs associées à c-hck."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent survenir avec les traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent fatigue, nausées et immunosuppression."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec c-hck ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la progression du cancer et la métastase à d'autres organes."
}
},
{
"@type": "Question",
"name": "Les anomalies de c-hck affectent-elles la survie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent réduire la survie globale en raison de la gravité du cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées aux traitements ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des complications comme des infections ou des saignements."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à c-hck ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi médical régulier et des traitements symptomatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour c-hck ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le tabagisme et l'exposition à des agents carcinogènes."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour c-hck ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de développer des anomalies de c-hck augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de cancer."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur c-hck ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut affaiblir le système immunitaire, augmentant le risque de cancer."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques carcinogènes est un facteur de risque connu."
}
}
]
}
]
}
Continuous monitoring and treatment of patients in intensive care units generates vast amounts of data. Critical Care Medicine clinicians incorporate this continuously evolving data to make split-seco...
Building on previous work to define the scientific discipline of biomedical informatics, we present a framework that categorizes fundamental challenges into groups based on data, information, and know...
A novel interprofessional clinical informatics curriculum was developed, piloted, and implemented, using an academic medical record. Targeted learners included undergraduate, graduate, and professiona...
In 2009, Schattauer Verlag in Stuttgart, Germany first published the...
Leaders in Informatics, Quality, and Systems (LInQS) is a non-ACGME (Accreditation Council for Graduate Medical Education)-accredited 2-year training program developed to enhance training in the field...
This single-institution 2-year longitudinal training program grounded in QI and informed by leadership and clinical informatics includes didactics, coaching, and mentorship, all centered around indivi...
From 2019 to 2023, 32 fellows have been accepted into the program with 13 graduates and 16 currently enrolled. Fellows have been predominately female, physicians, and from multiple specialties but pre...
Our experience supports the need to provide health care providers more expansive training in the areas of QI, clinical informatics, and leadership for improving health care delivery. Additional in-dep...
As the informatics community commits to the goal of advancing health equity, it is essential that we openly critique our current approaches and reimagine the ways in which we design, implement, evalua...
A brief history of the book series launched by Springer-Verlag in 1988 as Computers in Healthcare stands as a case study of its role in the development of informatics in medicine. Renamed Health Infor...
Health care has evolved to support the involvement of individuals in decision making by, for example, using mobile apps and wearables that may help empower people to actively participate in their trea...
This article proposes a preliminary definition of PHI and defines the scope of the field....
We used an adapted Delphi study design to gain consensus from participants on a definition developed from a previous review of literature. From the literature we derived a set of attributes describing...
The first round had 44 participants, with 28 participants participating in all three rounds. These 28 participants were gender-balanced and comprised participants from industry, academia, and health s...
The consensus reached on attributes of PHI describe PHI as a multidisciplinary field that uses information technology and delivers tools with a focus on individual-centered care. It studies various ef...
We have proposed a preliminary definition, aims, and relationships of PHI based on literature and expert consensus. These can begin to be used to support development of research priorities and outcome...
Primary care informatics (PCI) professionals address workflow and technology solutions in a wide spectrum of health, ranging from optimizing the experience of the individual patient in the clinic room...
There is growing attention to health equity in health informatics research. However, the literature lacks a comprehensive framework outlining critical considerations for health informatics research wi...
Literature review and experiences from nine equity-focused health informatics conducted in the United States and Canada. Studies focus on disparities related to age, disability or chronic illness, gen...
We found four key equity-related methodological considerations. To assist informaticists in addressing equity, we contribute a novel framework to synthesize these four considerations: PRAXIS (Particip...
This framework can assist informaticists in systematically addressing these considerations in their research in four research stages: project initiation; sampling and recruitment; data collection; and...